BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10966344)

  • 1. CNS toxicity after topical application of EMLA cream on a toddler with molluscum contagiosum.
    Rincon E; Baker RL; Iglesias AJ; Duarte AM
    Pediatr Emerg Care; 2000 Aug; 16(4):252-4. PubMed ID: 10966344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizures and Methemoglobinemia After Topical Application of Eutectic Mixture of Lidocaine and Prilocaine on a 3.5-Year-Old Child with Molluscum Contagiosum and Atopic Dermatitis.
    Cho YS; Chung BY; Park CW; Kim HO
    Pediatr Dermatol; 2016 Sep; 33(5):e284-5. PubMed ID: 27397059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMLA cream provides rapid pain relief for the curettage of molluscum contagiosum in children with atopic dermatitis without causing serious application-site reactions.
    Rönnerfält L; Fransson J; Wahlgren CF
    Pediatr Dermatol; 1998; 15(4):309-12. PubMed ID: 9720701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Purpura after application of a eutectic mixture of local anesthetic].
    Cervigón I; Torres-Iglesias LM; Palomo A
    Actas Dermosifiliogr; 2008; 99(6):499-500. PubMed ID: 18558068
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of systemic toxicity with topical lidocaine/prilocaine: a review.
    Tran AN; Koo JY
    J Drugs Dermatol; 2014 Sep; 13(9):1118-22. PubMed ID: 25226014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of molluscum contagiosum using a lidocaine/prilocaine cream (EMLA) for analgesia.
    de Waard-van der Spek FB; Oranje AP; Lillieborg S; Hop WC; Stolz E
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 1):685-8. PubMed ID: 2229496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methemoglobinemia and CNS toxicity after topical application of EMLA to a 4-year-old girl with molluscum contagiosum.
    Raso SM; Fernandez JB; Beobide EA; Landaluce AF
    Pediatr Dermatol; 2006; 23(6):592-3. PubMed ID: 17156008
    [No Abstract]   [Full Text] [Related]  

  • 8. Lidocaine and prilocaine toxicity in a patient receiving treatment for mollusca contagiosa.
    Touma S; Jackson JB
    J Am Acad Dermatol; 2001 Feb; 44(2 Suppl):399-400. PubMed ID: 11174427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of EMLA cream in pediatrics].
    Lorette G
    Ann Dermatol Venereol; 1999 Mar; 126(3):286-90. PubMed ID: 10394447
    [No Abstract]   [Full Text] [Related]  

  • 10. [Coma in a child after treatment with the 'magic salve' lidocaine-prilocaine cream].
    Wieringa JW; Ketel AG; van Houten MA
    Ned Tijdschr Geneeskd; 2006 Aug; 150(33):1805-7. PubMed ID: 16967588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Convulsions after EMLA cream application].
    Plee Y; Jonville-Béra AP; Bourgade B; Lacombe A; Paintaud G; Autret-Leca E
    Arch Pediatr; 1999 Jan; 6(1):105. PubMed ID: 9974106
    [No Abstract]   [Full Text] [Related]  

  • 12. [Coma in a child after treatment with the 'magic salve' lidocaine-prilocaine cream].
    Eekhof JA; de Kanter JS; Assendelf WJ; Krijger JM; Bouvy ML; Cheung KC
    Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2729-30; author reply 2730. PubMed ID: 17195320
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergic contact dermatitis from EMLA cream in a hemodialyzed patient.
    Pérez-Pérez LC; Fernández-Redondo V; Ginarte-Val M; Paredes-Suárez C; Toribio J
    Dermatitis; 2006 Jun; 17(2):85-7. PubMed ID: 16956458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizures and methemoglobinemia in an infant after excessive EMLA application.
    Larson A; Stidham T; Banerji S; Kaufman J
    Pediatr Emerg Care; 2013 Mar; 29(3):377-9. PubMed ID: 23462397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purpura caused by Emla is of toxic origin.
    de Waard-van der Spek FB; Oranje AP
    Contact Dermatitis; 1997 Jan; 36(1):11-3. PubMed ID: 9034681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimized use of Emla cream in children--secondary publication. A randomized, prospective, controlled comparison of two application regimes].
    Gad LN; Olsen KS; Lysgaard AB; Culmsee MB
    Ugeskr Laeger; 2005 Jan; 167(4):404-7. PubMed ID: 15719567
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with percutaneous anesthesia using a lidocaine-prilocaine cream (EMLA 5% cream)].
    Wagner G; Mensing H
    Z Hautkr; 1989 Aug; 64(8):688-90, 693. PubMed ID: 2800664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methaemoglobinaemia in a child treated with Emla(®) cream: circumstances and consequences of overdose].
    Schmitt C; Matulic M; Kervégant M; Tichadou L; Boutin A; Glaizal M; de Haro L
    Ann Dermatol Venereol; 2012 Dec; 139(12):824-7. PubMed ID: 23237281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pain from heel lance with lidocaine-prilocaine (EMLA) cream: is it safe and efficacious in preterm infants?
    Stevens B; Johnston C; Taddio A; Jack A; Narciso J; Stremler R; Koren G; Aranda J
    J Dev Behav Pediatr; 1999 Aug; 20(4):216-21. PubMed ID: 10475595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathology of an adverse reaction to a eutectic mixture of the local anesthetics lidocaine and prilocaine.
    Hoss DM; Gross EG; Grant-Kels JM
    J Cutan Pathol; 1999 Feb; 26(2):100-4. PubMed ID: 10082401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.